[1]Patent:US2009/318473,2009,A1.Locationinpatent:Page/Pagecolumn28
1256345-57-9
1256345-51-3
1256346-11-8
1256346-14-1
1256346-35-6
854778-30-6
913297-04-8 | 2-(2-Chlorophenyl)morpholine oxalate | AA006CE4 | MFCD03840016
68214-07-3 | Cetyltrimethylammonium hydrogensulfate | AA006D3B | MFCD00134393
68161-60-4 | 5-(4-Ethoxy-phenylamino)-[1,3,4]thiadiazole-2-thiol | AA006E4R | MFCD02956713
934-80-5 | 4-Ethyl-o-xylene | AA006FBL | MFCD00059234
933752-44-4 | 5-bromo-1,3-thiazole-2-carbaldehyde | AA006G4M | MFCD09870032
90905-33-2 | 2-Methylpyrimidine-5-carbaldehyde | AA006GLW | MFCD07186434
901586-60-5 | 4-(4-Chloro-6-ethylpyrimidin-2-yl)morpholine | AA006HVU | MFCD08060016
930-42-7 | 4-Bromo-3-methylisothiazole | AA006J2X | MFCD11110311
66047-01-6 | Ethyl 2-(m-tolyloxy)acetate | AA006KF2 | MFCD01162421
914613-35-7 | 1H-1-Ethyl Candesartan Cilexetil | AA006M7W | MFCD18382323